Genome-wide methylation analysis of GBM has revealed biologically distinctive DNA methylation events within the promoter region of the MGMT (O6-methyl guanine DNA methyltransferase) gene, as well as CD81, which is involved in DNA repair and radioresistance in a substantial proportion of GBM patients. The gene discussed is CD81; the disease is glioblastoma.